Drug Shortage Report for MINT-AMLODIPINE
Report ID | 30002 |
Drug Identification Number | 02362651 |
Brand name | MINT-AMLODIPINE |
Common or Proper name | Amlodipine |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | AMLODIPINE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 250 Count bottles |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2017-11-21 |
Actual start date | 2017-11-21 |
Estimated end date | 2018-01-12 |
Actual end date | 2018-01-10 |
Shortage status | Resolved |
Updated date | 2018-01-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-01-11 | English | Compare |
v9 | 2018-01-10 | French | Compare |
v8 | 2018-01-10 | English | Compare |
v7 | 2018-01-09 | French | Compare |
v6 | 2018-01-09 | English | Compare |
v5 | 2017-12-15 | French | Compare |
v4 | 2017-12-15 | English | Compare |
v3 | 2017-11-22 | English | Compare |
v2 | 2017-11-21 | French | Compare |
v1 | 2017-11-21 | English | Compare |
Showing 1 to 10 of 10